MGP
RVMD icon

M&G plc’s Revolution Medicines RVMD Stock Holding History

M&G plc’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$803K Sell
4,296
-70,437
-94% -$10.3M ﹤0.01% 323
2026
Q1 		$7.25M Sell
74,733
-14,219
-16% -$1.44M 0.04% 241
2025
Q4 		$7.12M Buy
+88,952
New +$5.83M 0.04% 244

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

M&G plc's RVMD Position: Q2 2026 in Review

M&G plc reduced its Revolution Medicines (RVMD) stake by 94% in Q2 2026, selling an estimated $10.3M and leaving 4,296 shares worth $803K. The position accounts for ﹤0.01% of the portfolio, ranked #323.

M&G plc first reported a position in RVMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.25M in Q1 2026. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • M&G plc held 4,296 shares of Revolution Medicines worth $803K as of Q2 2026.
  • M&G plc sold 70,437 Revolution Medicines shares in Q2 2026, an estimated $10.3M.
  • Revolution Medicines made up ﹤0.01% of M&G plc's portfolio in Q2 2026, its #323 holding.
  • M&G plc first reported a position in Revolution Medicines in Q4 2025 and has held it in 3 quarters since.
  • M&G plc's Revolution Medicines position peaked at $7.25M in Q1 2026.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on M&G plc's 13F filing for Q2 2026, filed 6 Aug 2026.